.png)
This journal has adopted the following models:
- Creative Commons Attribution License (CC-BY 2.0 UK)
- Publication Integrity and Ethics (P.I.E.) Guidelines
- Ethical Rules of Disclosure of the Association for Medical Ethics (AME)
- ICMJE Recommendations of the International Committee of Medical Journal Editors (ICMJE)
- Editorial Policy Statements of the Council of Science Editors (CSE)
Tracked/indexed by:
Google Scholar, CAS, JournalTOCs, JournalSeek, CrossRef, EZB Nutzeranfragen, AcademicKeys, RoMEO, CNKI, J-Gate, P.I.E. journal
OAPL (UK) archiving provider: British Library
Our publisher has negotiated a discount for its editors, reviewers and authors to undertake (distant learning- fully online) short courses related to research integrity and publication ethics, law and medical ethics, research governance, good ethical practice, leadership and management. These courses are approved by the Publication Integrity & Ethics.
A UK-based not-for-profit organization promoting integrity and ethics in the publishing sector through its guidelines and code of conduct.
P.I.E.'s main aim is to pave the way for a better publishing ethical environment that sets out the standards of a good and ethical editorial behaviour.
Whilst P.I.E. (π) promotes editorial freedom, at the same time, it also ensures that this freedom is not violated by editorial misconduct and plagiarism.
OAPL authors may choose to include the
OAPL standard ethics statements
in their submitted articles. It is assumed that all submitted original research studies, research studies, hypothesis, methodologies, short communications, case studies, case reports & case series have been conducted to the highest ethical standards.
Prasad R, Gupta V, Kumar A. Advances on molecular basis of clear cell renal cell carcinoma. OA Cancer 2014 May 23;2(1):8.
High Impact
Nowak K, Eldredge-Hindy H, Champ CE. Metformin: The sweet link between tumor genetics and metabolism? OA Cancer 2014 Apr 09;2(1):7.
High Impact
Choong KC, Ammori JB. Surgical management of colorectal liver metastases. OA Cancer 2014 Mar 10;2(1):6.
High Impact
Tsuboy MS, Marcarini JC, de Souza AO, de Paula NA, Luiz RC, Dorta DJ, Mantovani MS, Ribeiro LR. Effects of physiological levels of daidzein on cell proliferation of tumoral and non-tumoral breast cells lines. OA Cancer 2014 Mar 10;2(1):5.
High Impact
Yashiro M, Matsuoka T. Scirrhous gastric cancer: a critical review. OA Cancer 2014 Feb 25;2(1):4.
High Impact
Pascu O, Ciobanu L. Usefulness of capsule endoscopy in digestive tract tumours. OA Cancer 2014 Feb 25;2(1):3.
High Impact
Isra?l M. Cancer metabolism: an alteration of the anabolic−catabolic selection switch. OA Cancer 2014 Jan 18;2(1):1.
High Impact
Pan Y. Role of Stat3 in nasopharyngeal carcinoma. OA Cancer 2013 Dec 30;1(2):17.
High Impact
Liu J, Shen JX, Hu JL, Dou XW, Zhang GJ. Role of epithelial?mesenchymal transition in invasion and metastasis of breast cancers. OA Cancer 2013 Dec 30;1(2):16.
High Impact
Cordon CS, Piva MBR, Melo CM, Pinhal MAS, Suarez ER. Nanoparticles as platforms of molecular delivery in diagnosis and therapy. OA Cancer 2013 Dec 01;1(2):15.
High Impact
Chellaiah MA. CD44-Src signalling promotes invadopodia formation in prostate cancer (PC3) cells. OA Cancer 2013 Nov 01;1(2):14.
High Impact
Wall LR, Ward EC, Cartmill B, Hill AJ. Technology-assisted screening of patient-reported functional outcomes in the head and neck cancer population: What?s the evidence? OA Cancer 2013 Oct 01;1(2):13.
High Impact
Kontos CK. Molecular biomarkers of prognosis in laryngeal squamous cell carcinoma. OA Cancer 2013 Sep 01;1(2):12.
High Impact
Firer MA. Antibody-drug conjugates in cancer therapy?filling in the potholes that lie ahead. OA Cancer 2013 Jun 19;1(1):8.
High Impact
Isra?l M. Nutrition-dependent GABA deficiencies in endocrine pancreas causes cancer as shown for betel nut consumers and for diets with low vitamin B6. OA Cancer 2013 May 01;1(1):2.
High Impact
Luo S, Wang LF, Ding WJ, Wang H, Zhou JM, Jin HK, Su SF, Ouyang WW. Clinical trials of magnetic induction hyperthermia for treatment of tumours. OA Cancer 2014 Jan 18;2(1):2.
High Impact
Yashiro M, Matsuoka T. Scirrhous gastric cancer: a critical review. OA Cancer 2014 Feb 25;2(1):4.
High Impact
Nowak K, Eldredge-Hindy H, Champ CE. Metformin: The sweet link between tumor genetics and metabolism? OA Cancer 2014 Apr 09;2(1):7.
High Impact
Daroux-Cole L, Pettengell R, Jewell A. Exercise for cancer survivors: A review. OA Cancer 2013 May 20;1(1):5.
High Impact
Pan Y. Role of Stat3 in nasopharyngeal carcinoma. OA Cancer 2013 Dec 30;1(2):17.
High Impact
Chua MJ, Tiash S, Fatemian T, Noordin MI, Keng CS, Chowdhury EH. Carbonate apatite-facilitated intracellular delivery of c-ROS1 small interfering RNA sensitises MCF-7 breast cancer cells to cisplatin and paclitaxel. OA Cancer 2013 Jun 19;1(1):7.
High Impact
Liu J, Shen JX, Hu JL, Dou XW, Zhang GJ. Role of epithelial?mesenchymal transition in invasion and metastasis of breast cancers. OA Cancer 2013 Dec 30;1(2):16.
High Impact
Isra?l M. Cancer metabolism: an alteration of the anabolic−catabolic selection switch. OA Cancer 2014 Jan 18;2(1):1.
High Impact
Corso G, Marrelli D, Roviello F. E-cadherin germline missense mutations in diffuse gastric cancer. OA Cancer 2013 May 20;1(1):4.
High Impact
Chellaiah MA. CD44-Src signalling promotes invadopodia formation in prostate cancer (PC3) cells. OA Cancer 2013 Nov 01;1(2):14.
High Impact
Pascu O, Ciobanu L. Usefulness of capsule endoscopy in digestive tract tumours. OA Cancer 2014 Feb 25;2(1):3.
High Impact
Prasad R, Gupta V, Kumar A. Advances on molecular basis of clear cell renal cell carcinoma. OA Cancer 2014 May 23;2(1):8.
High Impact
Nowak K, Eldredge-Hindy H, Champ CE. Metformin: The sweet link between tumor genetics and metabolism? OA Cancer 2014 Apr 09;2(1):7.
High Impact
Choong KC, Ammori JB. Surgical management of colorectal liver metastases. OA Cancer 2014 Mar 10;2(1):6.
High Impact
Tsuboy MS, Marcarini JC, de Souza AO, de Paula NA, Luiz RC, Dorta DJ, Mantovani MS, Ribeiro LR. Effects of physiological levels of daidzein on cell proliferation of tumoral and non-tumoral breast cells lines. OA Cancer 2014 Mar 10;2(1):5.
High Impact
Yashiro M, Matsuoka T. Scirrhous gastric cancer: a critical review. OA Cancer 2014 Feb 25;2(1):4.
High Impact
Pascu O, Ciobanu L. Usefulness of capsule endoscopy in digestive tract tumours. OA Cancer 2014 Feb 25;2(1):3.
High Impact
Luo S, Wang LF, Ding WJ, Wang H, Zhou JM, Jin HK, Su SF, Ouyang WW. Clinical trials of magnetic induction hyperthermia for treatment of tumours. OA Cancer 2014 Jan 18;2(1):2.
High Impact
Isra?l M. Cancer metabolism: an alteration of the anabolic−catabolic selection switch. OA Cancer 2014 Jan 18;2(1):1.
High Impact
Pan Y. Role of Stat3 in nasopharyngeal carcinoma. OA Cancer 2013 Dec 30;1(2):17.
High Impact
Liu J, Shen JX, Hu JL, Dou XW, Zhang GJ. Role of epithelial?mesenchymal transition in invasion and metastasis of breast cancers. OA Cancer 2013 Dec 30;1(2):16.
High Impact
Cordon CS, Piva MBR, Melo CM, Pinhal MAS, Suarez ER. Nanoparticles as platforms of molecular delivery in diagnosis and therapy. OA Cancer 2013 Dec 01;1(2):15.
High Impact
Chellaiah MA. CD44-Src signalling promotes invadopodia formation in prostate cancer (PC3) cells. OA Cancer 2013 Nov 01;1(2):14.
High Impact
Wall LR, Ward EC, Cartmill B, Hill AJ. Technology-assisted screening of patient-reported functional outcomes in the head and neck cancer population: What?s the evidence? OA Cancer 2013 Oct 01;1(2):13.
High Impact
